PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 48 filers reported holding PROQR THRAPEUTICS N V in Q4 2020. The put-call ratio across all filers is 13.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19 | +90.0% | 14,689 | +124.9% | 0.00% | – |
| Q2 2023 | $10 | -94.5% | 6,530 | -92.4% | 0.00% | – |
| Q1 2023 | $183 | +40.8% | 86,152 | +143.6% | 0.00% | – |
| Q4 2022 | $130 | -87.0% | 35,365 | +1347.6% | 0.00% | – |
| Q3 2022 | $1,000 | – | 2,443 | +5581.4% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 43 | -99.7% | 0.00% | – |
| Q4 2021 | $130,000 | -83.9% | 16,291 | -86.7% | 0.00% | -100.0% |
| Q1 2021 | $807,000 | +6625.0% | 122,183 | +3990.5% | 0.00% | – |
| Q4 2020 | $12,000 | – | 2,987 | +18568.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 16 | -99.1% | 0.00% | – |
| Q2 2020 | $11,000 | -91.8% | 1,853 | -92.4% | 0.00% | – |
| Q1 2020 | $134,000 | – | 24,484 | +24384.0% | 0.00% | – |
| Q3 2019 | $0 | – | 100 | +92.3% | 0.00% | – |
| Q1 2019 | $0 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |